Cellectis S.A. (EPA:ALCLS)
3.296
-0.044 (-1.32%)
Apr 24, 2026, 1:53 PM CET
Cellectis Market Cap
Cellectis has a market cap or net worth of €242.45 million as of April 24, 2026. Its market cap has increased by 158.30% in one year.
Market Cap
242.45M
Enterprise Value
140.51M
Revenue
67.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.30
Market Cap Chart
Since February 7, 2007, Cellectis's market cap has increased from 100.59M to 242.45M, an increase of 141.02%. That is a compound annual growth rate of 4.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 242.45M | -20.09% |
| Dec 31, 2025 | 303.40M | 158.68% |
| Dec 31, 2024 | 117.29M | -40.86% |
| Dec 29, 2023 | 198.32M | 118.98% |
| Dec 30, 2022 | 90.57M | -73.23% |
| Dec 31, 2021 | 338.35M | -67.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MedinCell | 881.81M |
| Valneva SE | 450.54M |
| Genfit | 440.69M |
| Transgene | 208.15M |
| Sensorion | 192.51M |
| ABIONYX Pharma | 130.18M |
| Innate Pharma | 118.04M |
| Adocia | 112.07M |